Advertisement
UK markets close in 7 hours 39 minutes
  • FTSE 100

    8,354.99
    +0.94 (+0.01%)
     
  • FTSE 250

    20,482.28
    -9.71 (-0.05%)
     
  • AIM

    781.47
    +1.64 (+0.21%)
     
  • GBP/EUR

    1.1623
    +0.0000 (+0.00%)
     
  • GBP/USD

    1.2476
    -0.0022 (-0.17%)
     
  • Bitcoin GBP

    49,124.16
    -818.45 (-1.64%)
     
  • CMC Crypto 200

    1,309.29
    +9.19 (+0.71%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CRUDE OIL

    79.52
    +0.53 (+0.67%)
     
  • GOLD FUTURES

    2,316.30
    -6.00 (-0.26%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,514.09
    +200.23 (+1.09%)
     
  • DAX

    18,535.10
    +36.72 (+0.20%)
     
  • CAC 40

    8,125.85
    -5.56 (-0.07%)
     

Chemours to Raise Its Debt: Good or Bad?

Chemours to Raise Its Debt: Good or Bad?

It is now on its way to adding 450 million euros in 4% senior notes due 2026 through a public offering. This offer is managed jointly by Citigroup Global Markets, Deutsche Bank Securities, Merrill Lynch, HSBC Securities, and many others, and the debt includes long-term debt and current maturities. The proceeds from the offer are expected to be ~$557.5 million based on the exchange rate stated in the company’s SEC (Securities and Exchange Commission) filing.